Creutzfeldt-Jakob disease surveillance - Australia at the cross-roads?

Authors

  • Lance Sanders Surveillance and Management Section, Population Health Division, Department of Health and Aged Care, Canberra, ACT

DOI:

https://doi.org/10.33321/cdi.2000.24.44

Keywords:

Creutzfeldt-Jakob disease, surveillance

Downloads

Download data is not yet available.

References

Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.

Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-238.

Thadani V, Penar PL, Partington J et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 1988;69:766-769.

Fradkin JE, Schonberger LB, Mills JL et al. Creutzfeldt-Jakob disease in pituitary hormone recipients in the United States. JAMA 1991;265:880-884.

Esmonde T, Lueck CJ, Symon L, Duchen LW, Will RG. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993;56:999-1000.

Centers for Disease Control and Prevention. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979 - May 1996. MMWR 1997:46:1066-1069.

Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-697.

Kondo K, Kuriowa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377-381.

United Kingdom Department of Health. www.doh.gov.uk/cjd/stats/sept00.htm.

Lasmézas CI, Deslys JP, Demaimay R et al. BSE transmission to macaques. Nature 1996;381:743-744.

Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-690.

Hill AF, Desbruslais M, Joiner S et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-450.

Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.

Houston F, Foster J D, Chong A et al. Transmission of BSE by blood transfusion in sheep. Lancet 2000;356:999.

Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703-704.

Oppenheim C, Brandel JP, Hauw JJ, Deslys JP, Fontaine B. MRI and the second French case of vCJD. Lancet 2000;356:253-254.

Health Canada. Directive D2000-01. www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/btox/directiv/d2000-01_0830_e.pdf.

Downloads

Published

30/09/00

How to Cite

Sanders, Lance. 2000. “Creutzfeldt-Jakob Disease Surveillance - Australia at the Cross-Roads?”. Communicable Diseases Intelligence 24 (September):265-66. https://doi.org/10.33321/cdi.2000.24.44.